Position in RCUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,585,431
+$721,483 QoQ
Shares Held
83,861
-2.8% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 230 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,398 across 216 Biotechnology names. RCUS ranks #113 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in RCUS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,585,431 | 83,861 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $1,863,948 | 86,294 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,054,310 | 86,207 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,139,365 | 83,777 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $881,552 | 108,299 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $713,987 | 90,954 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $382,672 | 25,700 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $398,915 | 26,090 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $373,500 | 24,524 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $275,799 | 14,608 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $209,087 | 10,947 | Shares | Defined | 2024-02-14 | |
| 2023-03-31 | $4,035,727 | 221,257 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,501,535 | 120,964 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,142,025 | 120,108 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,782,238 | 70,333 | Shares | Defined | 2022-08-15 | |
| 2021-09-30 | $204,652 | 5,869 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,033,566 | 37,639 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,326,106 | 47,226 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,712,477 | 65,966 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,121,641 | 65,440 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,438,927 | 58,162 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $360,546 | 25,976 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||